Cargando…

Cryptosporidium uses CSpV1 to activate host type I interferon and attenuate antiparasitic defenses

Cryptosporidium infects gastrointestinal epithelium and is a leading cause of infectious diarrhea and diarrheal-related death in children worldwide. There are no vaccines and no fully effective therapy available for the infection. Type II and III interferon (IFN) responses are important determinants...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Silu, He, Wei, Gong, Ai-Yu, Li, Min, Wang, Yang, Xia, Zijie, Zhang, Xin-Tiang, Huang Pacheco, Andrew S., Naqib, Ankur, Jenkins, Mark, Swanson, Patrick C., Drescher, Kristen M., Strauss-Soukup, Juliane K., Belshan, Michael, Chen, Xian-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020566/
https://www.ncbi.nlm.nih.gov/pubmed/36928642
http://dx.doi.org/10.1038/s41467-023-37129-0
_version_ 1784908287615959040
author Deng, Silu
He, Wei
Gong, Ai-Yu
Li, Min
Wang, Yang
Xia, Zijie
Zhang, Xin-Tiang
Huang Pacheco, Andrew S.
Naqib, Ankur
Jenkins, Mark
Swanson, Patrick C.
Drescher, Kristen M.
Strauss-Soukup, Juliane K.
Belshan, Michael
Chen, Xian-Ming
author_facet Deng, Silu
He, Wei
Gong, Ai-Yu
Li, Min
Wang, Yang
Xia, Zijie
Zhang, Xin-Tiang
Huang Pacheco, Andrew S.
Naqib, Ankur
Jenkins, Mark
Swanson, Patrick C.
Drescher, Kristen M.
Strauss-Soukup, Juliane K.
Belshan, Michael
Chen, Xian-Ming
author_sort Deng, Silu
collection PubMed
description Cryptosporidium infects gastrointestinal epithelium and is a leading cause of infectious diarrhea and diarrheal-related death in children worldwide. There are no vaccines and no fully effective therapy available for the infection. Type II and III interferon (IFN) responses are important determinants of susceptibility to infection but the role for type I IFN response remains obscure. Cryptosporidium parvum virus 1 (CSpV1) is a double-stranded RNA (dsRNA) virus harbored by Cryptosporidium spp. Here we show that intestinal epithelial conditional Ifnar1(−/−) mice (deficient in type I IFN receptor) are resistant to C. parvum infection. CSpV1-dsRNAs are delivered into host cells and trigger type I IFN response in infected cells. Whereas C. parvum infection attenuates epithelial response to IFN-γ, loss of type I IFN signaling or inhibition of CSpV1-dsRNA delivery can restore IFN-γ-mediated protective response. Our findings demonstrate that type I IFN signaling in intestinal epithelial cells is detrimental to intestinal anti-C. parvum defense and Cryptosporidium uses CSpV1 to activate type I IFN signaling to evade epithelial antiparasitic response.
format Online
Article
Text
id pubmed-10020566
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-100205662023-03-18 Cryptosporidium uses CSpV1 to activate host type I interferon and attenuate antiparasitic defenses Deng, Silu He, Wei Gong, Ai-Yu Li, Min Wang, Yang Xia, Zijie Zhang, Xin-Tiang Huang Pacheco, Andrew S. Naqib, Ankur Jenkins, Mark Swanson, Patrick C. Drescher, Kristen M. Strauss-Soukup, Juliane K. Belshan, Michael Chen, Xian-Ming Nat Commun Article Cryptosporidium infects gastrointestinal epithelium and is a leading cause of infectious diarrhea and diarrheal-related death in children worldwide. There are no vaccines and no fully effective therapy available for the infection. Type II and III interferon (IFN) responses are important determinants of susceptibility to infection but the role for type I IFN response remains obscure. Cryptosporidium parvum virus 1 (CSpV1) is a double-stranded RNA (dsRNA) virus harbored by Cryptosporidium spp. Here we show that intestinal epithelial conditional Ifnar1(−/−) mice (deficient in type I IFN receptor) are resistant to C. parvum infection. CSpV1-dsRNAs are delivered into host cells and trigger type I IFN response in infected cells. Whereas C. parvum infection attenuates epithelial response to IFN-γ, loss of type I IFN signaling or inhibition of CSpV1-dsRNA delivery can restore IFN-γ-mediated protective response. Our findings demonstrate that type I IFN signaling in intestinal epithelial cells is detrimental to intestinal anti-C. parvum defense and Cryptosporidium uses CSpV1 to activate type I IFN signaling to evade epithelial antiparasitic response. Nature Publishing Group UK 2023-03-16 /pmc/articles/PMC10020566/ /pubmed/36928642 http://dx.doi.org/10.1038/s41467-023-37129-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Deng, Silu
He, Wei
Gong, Ai-Yu
Li, Min
Wang, Yang
Xia, Zijie
Zhang, Xin-Tiang
Huang Pacheco, Andrew S.
Naqib, Ankur
Jenkins, Mark
Swanson, Patrick C.
Drescher, Kristen M.
Strauss-Soukup, Juliane K.
Belshan, Michael
Chen, Xian-Ming
Cryptosporidium uses CSpV1 to activate host type I interferon and attenuate antiparasitic defenses
title Cryptosporidium uses CSpV1 to activate host type I interferon and attenuate antiparasitic defenses
title_full Cryptosporidium uses CSpV1 to activate host type I interferon and attenuate antiparasitic defenses
title_fullStr Cryptosporidium uses CSpV1 to activate host type I interferon and attenuate antiparasitic defenses
title_full_unstemmed Cryptosporidium uses CSpV1 to activate host type I interferon and attenuate antiparasitic defenses
title_short Cryptosporidium uses CSpV1 to activate host type I interferon and attenuate antiparasitic defenses
title_sort cryptosporidium uses cspv1 to activate host type i interferon and attenuate antiparasitic defenses
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020566/
https://www.ncbi.nlm.nih.gov/pubmed/36928642
http://dx.doi.org/10.1038/s41467-023-37129-0
work_keys_str_mv AT dengsilu cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses
AT hewei cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses
AT gongaiyu cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses
AT limin cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses
AT wangyang cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses
AT xiazijie cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses
AT zhangxintiang cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses
AT huangpachecoandrews cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses
AT naqibankur cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses
AT jenkinsmark cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses
AT swansonpatrickc cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses
AT drescherkristenm cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses
AT strausssoukupjulianek cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses
AT belshanmichael cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses
AT chenxianming cryptosporidiumusescspv1toactivatehosttypeiinterferonandattenuateantiparasiticdefenses